Personalized blood pressure goals for people with HFpEF
Official title: Precision Blood Pressure Goals in Patients with Heart Failure with Preserved Ejection Fraction: A HeartShare Ancillary Study
Funded at Northwestern University · NIH-11279912 · Data updated 2026-11-12
A big study will look at how to best manage blood pressure for adults with heart failure with preserved ejection fraction to help reduce hospitalizations and improve survival.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 15, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $719,141 |
| NIH project number | 1R01HL183589-01 |
| Project ID | NIH-11279912 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults aged 21 and older with HFpEF who have hypertension and are managed with anti-hypertensive therapies.
✕Less likely to help
Patients without HFpEF or without hypertension may not benefit from the findings.
What this research studies
This project uses an AI-based approach to analyze real-world data on blood pressure, treatments, and outcomes in adults with HFpEF. It aims to identify how different BP targets affect health, recognizing that a single goal may not fit every patient. Researchers will examine patterns over time to see which factors modify the ideal BP, including comorbidities and treatment histories. The goal is to inform personalized BP management strategies for HFpEF patients.
Why it matters
Potential benefit: If successful, patients with HFpEF could receive more tailored blood pressure targets that reduce complications and improve quality of life.
How similar studies have gone: Previous large trials informed general BP targets, but this study focuses on HFpEF with personalized goals, which is a newer, data-driven approach.
Where this research is happening
-
Northwestern University
Chicago, United States Active
Researchers
- Principal investigator: Ahmad, Faraz Shafique — Northwestern University
- Study coordinator: Ahmad, Faraz Shafique
Related research
Other NIH-funded projects on the same topics.
-
MLK3 as a key mediator of PKG1 therapy in heart failure
A researcher is studying whether MLK3 helps PKG1-based treatments work better for people with heart failure.
-
Exploring a protein's role in heart failure treatment
This study is looking at how a protein called MLK3 affects heart failure and works with another important protein to help improve heart function, which could lead to better treatments for people with heart failure.
-
Actions to Decrease Disparities in Blood Pressure Control for Blacks
Aiming to help Black patients manage high blood pressure by using nurses, community health workers, and home monitoring in real-world clinics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Music-powered tools to boost blood pressure and stroke prevention for Nigerian youth and their older caregivers
This project uses popular music to help Nigerian youths and their older family members start and stick to blood pressure and stroke prevention habits.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.